君实生物-U
(688180)
| 流通市值：229.92亿 | | | 总市值：297.09亿 |
| 流通股本：7.63亿 | | | 总股本：9.86亿 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 |
| 每股收益(元) | -0.29 | -2.32 | -1.43 | -1.01 | -0.55 | -2.60 | -1.75 | -1.00 |
| 每股净资产(元) | 6.97 | 7.26 | 8.18 | 8.62 | 9.08 | 9.65 | 7.18 | 7.81 |
| 每股资本公积金(元) | 15.62 | 15.62 | 15.62 | 15.61 | 15.60 | 15.61 | 12.76 | 12.73 |
| 每股未分配利润(元) | -9.48 | -9.19 | -8.30 | -7.89 | -7.43 | -6.89 | -6.56 | -5.81 |
| 每股经营性现金流(元) | -0.38 | -2.03 | -1.69 | -1.24 | -0.73 | -1.81 | -1.22 | -0.50 |
| 净资产收益率(%) | -4.04 | -27.32 | -15.95 | -11.04 | -5.92 | -32.65 | -21.72 | -11.94 |
| 营业总收入(元) | 3.81亿 | 15.03亿 | 9.86亿 | 6.70亿 | 2.55亿 | 14.53亿 | 12.18亿 | 9.46亿 |
营业总收入同比增长(%) | 49.24 | 3.38 | -19.04 | -29.21 | -59.47 | -63.89 | -55.18 | -55.26 | | 归属净利润(元) | -28302.91万 | -228343.19万 | -140681.84万 | -99741.24万 | -54343.23万 | -238804.99万 | -159472.96万 | -91240.50万 |
| 归属净利润同比增长(%) | 47.92 | 4.38 | 11.78 | -9.32 | -37.09 | -231.26 | -306.69 | -9861.53 |
| 扣非净利润(元) | -30706.79万 | -229755.88万 | -135941.48万 | -97139.43万 | -55942.91万 | -245019.76万 | -164696.85万 | -94636.44万 |
|
| 扣非净利润同比增长(%) | 45.11 | 6.23 | 17.46 | -2.64 | -30.23 | -177.16 | -208.27 | -735.05 |
| 毛利率(%) | 71.61 | 64.00 | 65.85 | 62.35 | 66.49 | 65.30 | 64.93 | 67.59 |
| 净利率(%) | -78.69 | -168.76 | -157.65 | -168.18 | -250.68 | -177.78 | -142.36 | -105.64 |
| 资产负债率(%) | 41.63 | 35.46 | 28.04 | 25.42 | 23.55 | 22.15 | 27.94 | 23.84 |
| 存货周转率(次) | 0.20 | 0.95 | 0.50 | 0.40 | 0.15 | 0.93 | 0.84 | 0.60 |